BC
IMVT icon

Bridgefront Capital’s Immunovant IMVT Stock Holding History

Bridgefront Capital’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$691K Buy
+27,809
New +$720K 0.17% 201
2025
Q4 		– Sell
-13,654
Closed -$220K – 648
2025
Q3 		$220K Sell
13,654
-7,067
-34% -$114K 0.06% 495
2025
Q2 		$332K Sell
20,721
-15,338
-43% -$232K 0.09% 399
2025
Q1 		$616K Buy
+36,059
New +$754K 0.18% 198
2022
Q3 		– Sell
-15,649
Closed -$61K – 385
2022
Q2 		$61K Sell
15,649
-3,353
-18% -$14.5K 0.07% 280
2022
Q1 		$105K Buy
+19,002
New +$118K 0.13% 232
2021
Q3 		– Sell
-13,612
Closed -$144K – 506
2021
Q2 		$144K Buy
+13,612
New +$190K 0.05% 535

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return